Latest Gastroenterology research
The 10 most useful gastroenterology studies published this week, chosen from Q1 journals and graded on the Oxford CEBM evidence hierarchy. Each paper links to a short summary and the original on PubMed. Updated 22 September 2026.
Top 10 this week
Week of 20 September 2026
- 1
Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal
The New England journal of medicine · Q1 journal · RCT · Evidence level 1 (High) · 17 September 2026
In an interim analysis of 10,799 patients, cancers occurred in 0.77% of those screened at five years versus 0.82% at three years, meeting the predefined non-inferiority margin. The finding suggests that extending the first surveillance colonoscopy to five years may be safe for high-risk adenoma patients, though long-term outcomes remain to be confirmed.
- 2
Patient-level predictors of safety and recurrence after cold versus hot snare resection of large, non-pedunculated colorectal polyps: an individual patient data meta-analysis of four randomised-controlled trials
Gut · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 15 September 2026
In a pooled analysis of four RCTs involving 1,423 patients with large (at least 20 mm) non-pedunculated polyps, cold snare resection lowered major adverse events to 1.7% versus 5.9% with hot EMR, yet residual or recurrent adenoma rose to 26.5% compared with 12.8%. The trade-off may favor cold snare for sessile serrated lesions or high-risk patients, but higher recurrence-especially in high-grade dysplasia-remains a concern.
- 3
Self-expandable metal stents versus endoscopic balloon dilatation for the treatment of strictures in Crohn's disease: a retrospective long-term follow-up of the ProtDilat study, an open label, multicenter, randomized trial
Journal of Crohn's & colitis · Q1 journal · RCT · Evidence level 1 (High) · 3 September 2026
RCT of SEMS vs balloon dilation for Crohn’s strictures
- 4
EUS-Guided Cyanoacrylate Injection With Balloon-Compression Sclerotherapy Versus Band Ligation for Gastroesophageal Varices: A Randomized Trial
Journal of gastroenterology and hepatology · Q1 journal · RCT · Evidence level 1 (High) · 17 September 2026
Randomized trial of EUS‑CYA + bc‑EIS vs EVL for varices
- 5
Impact of gastric length of myotomy during POEM on the incidence of gastroesophageal reflux: A randomized controlled trial
Gastrointestinal endoscopy · Q1 journal · RCT · Evidence level 1 (High) · 18 September 2026
In a randomized trial of 100 achalasia patients, those receiving a gastric myotomy shorter than 3 cm developed LA grade B or higher esophagitis in 24% versus 44% with longer cuts, while symptom scores and treatment success were similar. The finding suggests a shorter myotomy may lower endoscopic reflux risk without compromising efficacy, but longer follow-up is needed.
- 6
Impact of early enteral nutrition on children with acute pancreatitis: A systematic review and meta analysis
Journal of pediatric gastroenterology and nutrition · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 14 September 2026
Meta-analysis of early enteral nutrition in acute pancreatitis
- 7
The Society of Thoracic Surgeons (2026) Expert Consensus Document on Management of Esophageal Perforation
The Annals of thoracic surgery · Q1 journal · Guideline · Evidence level 1 (High) · 17 September 2026
Esophageal perforation consensus, thoracic surgery focus
- 8
Impact of non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) on pain in patients with chronic pancreatitis: a double-blind, parallel-group, placebo-controlled, randomised trial
Gut · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026
No significant pain improvement with NEPERT vs placebo
- 9
Beyond Weight Reduction: An Updated Systematic Review and Meta-Analysis of Metabolic Syndrome Components and Metabolic Dysfunction-Associated Steatotic Liver Disease Outcomes After Endoscopic Sleeve Gastroplasty
Journal of clinical medicine · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 27 August 2026
In 12-month follow-up of 4,452 obese adults, ESG produced an average 0.33% drop in glycated haemoglobin, along with modest improvements in insulin resistance, triglycerides, LDL cholesterol and liver enzyme scores, while achieving roughly 16% weight loss. Evidence quality was low and the liver benefit may be weight-dependent, so larger randomized trials with biopsy endpoints are still needed.
- 10
Nicergoline for Neuromuscular Oropharyngeal Dysphagia: A Double-Blind, Placebo-Controlled Randomized Trial
Dysphagia · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026
In a 4-week double-blind trial of 44 patients with neuromuscular oropharyngeal dysphagia, nicergoline 30 mg daily reduced penetration-aspiration scale scores compared with placebo, indicating better airway protection during swallowing. Subjective and endoscopic swallow scores did not differ, so the benefit appears limited to reducing aspiration risk, warranting larger studies to confirm clinical impact.
Paper of the day, last two weeks
Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas
Alimentary pharmacology & therapeutics · Q1 journal · RCT · Evidence level 1 (High) · 11 September 2026
Randomised cross‑over trial of methylcellulose vs psyllium on gas
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Radiology · Q1 journal · Cohort · Evidence level 3 (Low) · 1 September 2026
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Radiology · Q1 journal · Cohort · Evidence level 3 (Low) · 1 September 2026
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Radiology · Q1 journal · Cohort · Evidence level 3 (Low) · 1 September 2026
Evaluation of Super-Resolution Contrast-enhanced US in Crohn Disease Activity Assessment
Additional Surgery versus Surveillance After Non-curative ESD for Early Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis
Gastrointestinal endoscopy · Q1 journal · SR of cohorts · Evidence level 2 (Moderate) · 9 September 2026
In a meta-analysis of 815 patients, patients who underwent surgery after a non-curative endoscopic resection had about a 60% lower risk of death from any cause compared with surveillance, and local tumor recurrence fell to one-sixth. Cancer-specific and distant recurrences were similar, so the benefit must be weighed against surgical risk, especially in older or frail patients.
Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study
Therapeutic advances in gastroenterology · Q1 journal · RCT · Evidence level 1 (High) · 4 September 2026
Real-world mirikizumab effectiveness in UC
Efficacy and Safety of a Novel All In One Device for Colorectal Hybrid ESD: A Multicenter Prospective Study
Clinical and translational gastroenterology · Q1 journal · Cohort · Evidence level 3 (Low) · 8 September 2026
Efficacy and Safety of a Novel All In One Device
Evidence summaries in Gastroenterology
- Acute Cholangitis
- Peptic Ulcer Disease
- Ulcerative Colitis
- Hepatocellular Carcinoma
- Achalasia
- Hepatitis C
- Gastroesophageal Reflux Disease
- Celiac Disease
- Spontaneous Bacterial Peritonitis
- Endoscopy
- Inflammatory Bowel Disease
- Crohn Disease
- Diverticulitis
- Acute Upper Gastrointestinal Bleeding
- Gastrointestinal Amyloidosis
Get this list every morning
The Web of Medicine app builds this feed for your specialty daily, with filters by evidence level and journal, audio summaries and Ask AI. Free on iOS and Android.
For healthcare professionals. Summaries are generated by AI from the published abstract and are not medical advice. Read the original paper before changing practice.